High-level resistance to gentamicin in clinical isolates of enterococci - PubMed (original) (raw)

High-level resistance to gentamicin in clinical isolates of enterococci

B D Mederski-Samoraj et al. J Infect Dis. 1983 Apr.

Abstract

Nine clinical isolates of Streptococcus faecalis from a university hospital were found to be resistant to high levels (minimal inhibitory concentration, greater than 2,000 micrograms/ml) of gentamicin, tobramycin, amikacin, streptomycin, and kanamycin. The high-level resistance to these aminoglycosides and resistance to penicillin-aminoglycoside synergism were transferable by conjugation to a susceptible recipient strain. In three strains tested, the aminoglycoside resistance was mediated by four aminoglycoside-modifying enzymes: a 3'-phosphotransferase transferred from two strains, a 2"-phosphotransferase and a 6'-acetyltransferase transferred from all three strains, and a streptomycin adenylyltransferase transferred from two strains. This is the first report of the occurrence of high-level gentamicin resistance in enterococcal isolates from the United States.

PubMed Disclaimer

Similar articles

• Transferable resistance and aminoglycoside-modifying enzymes in enterococci.
  Chen HY, Williams JD. Chen HY, et al. J Med Microbiol. 1985 Oct;20(2):187-96. doi: 10.1099/00222615-20-2-187. J Med Microbiol. 1985. PMID: 2995676
• Aminoglycoside-resistant enterococci.
  Basker MJ, Slocombe B, Sutherland R. Basker MJ, et al. J Clin Pathol. 1977 Apr;30(4):375-80. doi: 10.1136/jcp.30.4.375. J Clin Pathol. 1977. PMID: 404337 Free PMC article.
• Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.
  Krogstad DJ, Korfhagen TR, Moellering RC Jr, Wennersten C, Swartz MN. Krogstad DJ, et al. J Clin Invest. 1978 Aug;62(2):480-6. doi: 10.1172/JCI109149. J Clin Invest. 1978. PMID: 97312 Free PMC article.
• High-level aminoglycoside resistance in enterococci.
  Gutiérrez J, Hoyos A, Piedrola G. Gutiérrez J, et al. Ann Biol Clin (Paris). 1992;50(10-11):671-4. Ann Biol Clin (Paris). 1992. PMID: 1306949 Review.
• Aminoglycoside resistance in enterococci.
  Chow JW. Chow JW. Clin Infect Dis. 2000 Aug;31(2):586-9. doi: 10.1086/313949. Epub 2000 Sep 7. Clin Infect Dis. 2000. PMID: 10987725 Review.

Cited by

• Intrinsic and acquired resistance mechanisms in enterococcus.
  Hollenbeck BL, Rice LB. Hollenbeck BL, et al. Virulence. 2012 Aug 15;3(5):421-33. doi: 10.4161/viru.21282. Epub 2012 Aug 15. Virulence. 2012. PMID: 23076243 Free PMC article. Review.
• Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.
  Hodges TL, Zighelboim-Daum S, Eliopoulos GM, Wennersten C, Moellering RC Jr. Hodges TL, et al. Antimicrob Agents Chemother. 1992 Jan;36(1):121-5. doi: 10.1128/AAC.36.1.121. Antimicrob Agents Chemother. 1992. PMID: 1590676 Free PMC article.
• Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.
  Patterson JE, Masecar BL, Zervos MJ. Patterson JE, et al. Antimicrob Agents Chemother. 1988 Jan;32(1):122-4. doi: 10.1128/AAC.32.1.122. Antimicrob Agents Chemother. 1988. PMID: 3126703 Free PMC article.
• Comparison of the new MicroScan Pos MIC Type 6 panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species.
  Szeto S, Louie M, Low DE, Patel M, Simor AE. Szeto S, et al. J Clin Microbiol. 1991 Jun;29(6):1258-9. doi: 10.1128/jcm.29.6.1258-1259.1991. J Clin Microbiol. 1991. PMID: 1907610 Free PMC article.
• Aminoglycoside therapy: current and prospective uses.
  Leggett JE. Leggett JE. Tex Heart Inst J. 1990;17(4):330-6. Tex Heart Inst J. 1990. PMID: 15227525 Free PMC article. No abstract available.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems